Showing 2,501 - 2,520 results of 3,046 for search '"cardiac"', query time: 0.05s Refine Results
  1. 2501

    Diverse Patient Experiences of Internet-Based Cognitive Behavioral Therapy with Guided Peer Support for Generalized Anxiety Disorders by Jill Nault Connors PhD, MSSW, Ernani Magalhaes JD, Kevin Prather MSW, Nida Khan MD, Claire Draucker PhD, RN, FAAN, Johanne Eliacin PhD, HSPP, Chet Montgomery, Julie Hayden BS, Michael Millard MD, Kurt Kroenke MD, Paul Musey MD, MS, FACEP

    Published 2025-01-01
    “…Opportunities exist to improve patient experience in the emergency department for low-risk (ie, non-cardiac) chest pain patients with anxiety and panic as the underlying cause of symptoms. …”
    Get full text
    Article
  2. 2502

    Minimally Invasive Bilateral Lung Resections and CABG through 5 Ports by N. Asemota, M. J. Rouhani, L. Harling, H. Raubenheimer, A. C. De Souza, E. Lim

    Published 2018-01-01
    “…We present a case of a patient who underwent bilateral minimally invasive thoracic and cardiac surgery. An 81-year-old woman was diagnosed with T1aN0M0 left upper lobe small-cell lung cancer and underwent single-port left video-assisted thoracoscopic surgery (VATS) upper lobectomy in 2016. …”
    Get full text
    Article
  3. 2503
  4. 2504

    Sarcoglycans are enriched at the neuromuscular junction in a nerve-dependent manner by Michela Gloriani, Bianca Cheli, Chiara D’Ercole, Veronica Ruggieri, Marianna Cosentino, Mireia Serrat Pineda, Biliana Lozanoska-Ochser, Francesca Grassi, Marina Bouché, Luca Madaro, Carles Sánchez Riera

    Published 2025-01-01
    “…Although there are 6 different sarcoglycan isoforms, sarcoglycanopathies are caused exclusively by mutations in genes coding for one of the four sarcoglycan transmembrane proteins (alpha, beta, gamma and delta) forming the sarcoglycan complex (SGC) in skeletal and cardiac muscle. Little is known about the different roles of the SGC beyond the dystrophin glycoprotein complex (DGC) structural role. …”
    Get full text
    Article
  5. 2505

    New era, new GOALs: cardiovascular screening and lipid management in cystic fibrosis by Katherine A. Despotes, Agathe S. Ceppe, Jennifer L. Goralski, Scott H. Donaldson

    Published 2025-02-01
    “…In the past year, 29% of adult providers prescribed lipid-lowering therapy, 54% started anti-hypertensive medications, and 48% initiated ischemic cardiac evaluations for pwCF. Conclusion: TC significantly increased within 3 months of initiating ivacaftor, but subsequently diminished toward baseline by 18 months. …”
    Get full text
    Article
  6. 2506

    Can Serum Tenascin-C Be Used as a Marker of Inflammation in Patients with Dilated Cardiomyopathy? by Alyaa A. Kotby, Manal M. Abdel Aziz, Waleed M. El Guindy, Amira N. Moneer

    Published 2013-01-01
    “…Tenascin-C (TN-C) is an extracellular matrix glycoprotein that appears at sites of inflammation in cardiac pathologies. Aim of the Work. To evaluate the role of TN-C as a marker for active inflammation in children with dilated cardiomyopathy (DCM). …”
    Get full text
    Article
  7. 2507

    Data Mining for Identifying Novel Associations and Temporal Relationships with Charcot Foot by Michael E. Munson, James S. Wrobel, Crystal M. Holmes, David A. Hanauer

    Published 2014-01-01
    “…The three novel associations with the strongest temporal component were cardiac dysrhythmia, pulmonary eosinophilia, and volume depletion disorder. …”
    Get full text
    Article
  8. 2508

    The Role of PPARs in Lung Fibrosis by Heather F. Lakatos, Thomas H. Thatcher, R. Matthew Kottmann, Tatiana M. Garcia, Richard P. Phipps, Patricia J. Sime

    Published 2007-01-01
    “…PPARα agonists, including the hypolidipemic fibrate drugs, inhibit the production of collagen by hepatic stellate cells and inhibit liver, kidney, and cardiac fibrosis in animal models. In the mouse model of lung fibrosis induced by bleomycin, a PPARα agonist significantly inhibited the fibrotic response, while PPARα knockout mice developed more serious fibrosis. …”
    Get full text
    Article
  9. 2509

    Quantitative Complexity Theory Used in the Prediction of Head-Up Tilt Testing Outcome by Paweł Krzesiński, Jacek Marczyk, Bartosz Wolszczak, Grzegorz Gielerak

    Published 2021-01-01
    “…The chosen haemodynamic parameters (including BP, HR, stroke volume, cardiac output, systemic vascular resistance) have been used in complexity analysis. …”
    Get full text
    Article
  10. 2510

    Knowledge on hydroxychloroquine prescription and attitude toward its use in COVID-19 – A survey-based study among doctors by T P Afra, N A Uvais, Anuradha Bishnoi, Edavalath Sukesh, Salin Eliyas, N A Bishurul Hafi, T Muhammed Razmi

    Published 2021-01-01
    “…Contrary to the published guidelines/recommendations, 80% and 55.7% of respondents opined for routine cardiac and glucose-6-phosphate dehydrogenase evaluations before prescribing HCQ. …”
    Get full text
    Article
  11. 2511

    Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study by Kyle Murnaghan, Helen Bishop, Navjot Sandila, Bakhtiar Kidwai, Lawrence Title, Ata Ur Rehman Quraishi, Catherine Kells, Hussein Beydoun, Osama Elkhateeb

    Published 2022-01-01
    “…To determine the one-year and five-year occurrence and prognosticators of major adverse cardiac events (MACE: composition of all-cause death, myocardial infarction, target vessel revascularization, and vessel thrombosis), mortality, and target lesion revascularization (TLR) in patients with in-stent restenosis (ISR) treated with drug-eluting balloons (DEBs). …”
    Get full text
    Article
  12. 2512
  13. 2513

    An Alternative Method for Long-Term Culture of Chicken Embryonic Stem Cell In Vitro by Li Zhang, Yenan Wu, Xiang Li, Shao Wei, Yiming Xing, Zhengxing Lian, Hongbing Han

    Published 2018-01-01
    “…These cells also exhibited the capability to differentiate into cardiac myocytes, smooth muscle cells, neural cells, osteoblast, and adipocyte in vitro. …”
    Get full text
    Article
  14. 2514
  15. 2515

    Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study by Jing Li, Sanbao Chen, Sicong Ma, Mingque Yang, Zizhao Qi, Kun Na, Miaohan Qiu, Yi Li, Yaling Han

    Published 2022-01-01
    “…The secondary endpoints included 30-day major adverse cardiac and cerebral events (MACCEs), bleeding events defined according to the Bleeding Academic Research Consortium (BARC) definition, and stent thrombosis (ST). …”
    Get full text
    Article
  16. 2516

    Assessment of Myocardial Bridge and Mural Coronary Artery Using ECG-Gated 256-Slice CT Angiography: A Retrospective Study by En-sen Ma, Guo-lin Ma, Hong-wei Yu, Wang Wu, Kefeng Li

    Published 2013-01-01
    “…Recent clinical reports have indicated that myocardial bridge and mural coronary artery complex (MB-MCA) might cause major adverse cardiac events. 256-slice CT angiography (256-slice CTA) is a newly developed CT system with faster scanning and lower radiation dose compared with other CT systems. …”
    Get full text
    Article
  17. 2517

    Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease by Ryan Jalleh, Gopal Basu, Richard Le Leu, Shilpanjali Jesudason

    Published 2018-01-01
    “…Seven of the eight patients required inpatient management with three patients requiring intravenous calcium replacement and cardiac monitoring in a high dependency unit. Our study also identified additional factors that could potentially contribute to hypocalcaemia such as lack of calcium supplementation, use of noncalcium based phosphate binders, absence of or use of lower doses of calcitriol supplementation, low vitamin D levels, concomitant treatment with loop diuretics, history of parathyroidectomy, or presence of acute medical illness. …”
    Get full text
    Article
  18. 2518

    Scoliosis Surgery in Cystic Fibrosis: Surgical Considerations and the Multidisciplinary Approach of a Rare Case by George I. Mataliotakis, Athanasios I. Tsirikos, Karen Pearson, Don S. Urquhart, Carolyn Smith, Andrew Fall

    Published 2016-01-01
    “…Preoperative workup included respiratory, cardiac, anaesthetic, endocrine, and dietician reviews, as well as bone density optimisation with zoledronic acid and prophylactic antibiotics. …”
    Get full text
    Article
  19. 2519
  20. 2520

    A new perspective on cardiovascular function and dysfunction during endurance exercise: identifying the primary cause of cardiovascular risk by Amine Souissi, Ismail Dergaa, Samia Ernez Hajri, Karim Chamari, Helmi Ben Saad

    Published 2024-04-01
    “…The rise in heart rate in response to thermal stress is a cardiovascular response that increases cardiac output and skin blood flow. The cardiovascular response during endurance exercise is a complex phenomenon potentially influenced by the involvement of nitric oxide in active thermoregulatory vasodilation. …”
    Get full text
    Article